Skip to main content

Table 2 Properties of nosocomial infections treated by colistin and causative microorganisms

From: Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital

Indications of colistin treatment (%)]

 

   Culture-proven infection

36 (87.8%)

   Empirically

5 (12.2%)

Causative microorganism [number (%)]

 

   A. baumannii

20 (48.8%)

   P. aeruginosa

9 (22.0%)

   A. baumannii and P. aeruginosa

7 (17.1%)

   No microorganism

5 (12.2%)

Isolation sites of the microorganisms

 

   Tracheal aspirate fluid

24 (58.5%)

   Blood or central venous catheter tip

19 (46.3%)

   Skin swabs, conjunctival swabs

4 (9.8%)

   Cerebrospinal fluid

2 (4.9%)

Concomitant antimicrobial agent effective against gram negatives used with colistin [number (%)]

 

   Carbapenems

22 (53.7%)

   Aminoglycosides

14 (34.1%)

   Piperacillin-tazobactam

5 (12.2%)

   Cefoperazone-sulbactam

1 (2.4%)